Bone Biologics Corporation filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Weinberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 USD | 0.00% | -7.23% | -65.93% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.93% | 1.35M | |
+16.65% | 133B | |
-3.76% | 11.52B | |
-4.86% | 8.3B | |
-22.44% | 4.69B | |
+7.79% | 3.42B | |
-17.26% | 2.54B | |
-13.36% | 2.03B | |
-16.39% | 1.86B | |
-31.24% | 1.59B |
- Stock Market
- Equities
- BBLG Stock
- News Bone Biologics Corporation
- Bone Biologics Corporation Auditor Raises 'Going Concern' Doubt